Bumetanide 2 MG Oral Tablet
INDICATIONS AND USAGE Bumetanide tablets are indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome. Almost equal diuretic response occurs after oral and parenteral administration of bumetanide. Therefore, if impaired gastrointestinal absorption is suspected or oral administration is not practical, bumetanide should be given by the intramuscular or intravenous route. Successful treatment with bumetanide tablets following instances of allergic reactions to furosemide suggests a lack of cross-sensitivity.
Amneal Pharmaceuticals NY LLC
Related Pills
Bumetanide 0.5 MG Oral Tablet
amneal pharmaceuticals ny llc
Bumetanide 1 MG Oral Tablet
Amneal Pharmaceuticals NY LLC
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
BUMEtanIDE Tablets, USP for oral administration are available as:
BUMEtanIDE Tablets USP, 0.5 mg are supplied as white to off white, round biconvex, bisected and debossed “A” above and “16” below the bisect on one side and plain on the reverse side. They are available as follows: Bottles of 100: NDC 69238-1489-1 Bottles of 500: NDC 69238-1489-5
BUMEtanIDE Tablets USP, 1 mg are supplied as white to off white, round biconvex bisected and debossed “AC” above and “41” below the bisect on one side and plain on the reverse side. They are available as follows: Bottles of 100: NDC 69238-1490-1 Bottles of 500: NDC 69238-1490-5
BUMEtanIDE Tablets USP, 2 mg are supplied as white to off white, round, biconvex, bisected and debossed “AC” above and “42” below the bisect on one side and plain on the reverse side. They are available as follows: Bottles of 100: NDC 69238-1491-1 Bottles of 500: NDC 69238-1491-5 Storage: Store at 20˚ to 25˚C (68˚ to 77˚F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Dispense contents in a tight, light-resistant container as defined in the USP with a child- resistant closure, as required. Do not take improper broken tablets, if found in the container. Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Oral Solid Dosage Unit Ahmedabad 382213, INDIA Distributed by: Amneal Pharmaceuticals LLC Bridgewater, NJ 08807 Rev. 11-2019-03
More pills like ROUND AC 42